Hodgkin and non-hodgkin lymphoma Flashcards Preview

Blood and lymph exam 3 > Hodgkin and non-hodgkin lymphoma > Flashcards

Flashcards in Hodgkin and non-hodgkin lymphoma Deck (24)
Loading flashcards...
1
Q

Normal lymphoid structure

Which area of the lymph node has mixed population of cells but mostly T cells?

A
2
Q

The normal lymph node

Mixed B cells in the light zone of the germinal center are called_______.

B cells in the dark zone of the germinal center are called_______.

A
3
Q

What is a B specific cell marker?

What other markers are specific for B cells?

A

Cell markers for B cells: CD20 (in mantle zone and germinal center), CD19 and CD22

Cell markers for T cells are CD3 (positive in paracortical area)

and CD4, CD5, CD8.

4
Q

_____ and _____ are two markers that are specifically expressed in normal germinal B-cells and derived lymphomas

A
5
Q

Causes of lymphadenopathy (enlargement of lymph nodes):

A

-Reactive lymphoid hyperplasia due to:

oInfection (Viral, bacterial, fungal, parasitic)

oPost-vaccination

oAutoimmune disease (SLE, Kikuchi-Fujimoto)

oLocal/regional inflammatory disorders

Malignancy

oPrimary node neoplasms: Lymphoma

oDisseminated hematopoietic disease (acute leukemia involving lymph nodes)

o Metastatic non-hematopoietic neoplasms

6
Q

Lymphoma, what is it?

A

Criteria Used for classification and Grading of Lymphoma:

7
Q

Types of lymphoma

Which lymphoma is predominantly a B-cell lymphoma?

A

–>Non-Hodgkin’s lymphoma (NHL)

–Many types (***B-cell >**T-cell >*NK-cell)

–>Hodgkin lymphoma (HL): *B-cell lymphoma

oClassical HL

oNodular lymphocyte predominant HL

-->Lymphoblastic lymphoma/leukemia

8
Q

Chronic Lymphocytic Leukemia /
Small Lymphocytic Lymphoma (CLL/SLL)

Which one is characterized by peripheral blood lymphocytosis?

Which one is predomimantly extramedullary?

A

CLL: Peripheral blood lymphocytosis ≥5 × 109/L for ≥ 3 months; monoclonal mature lymphocytes

SLL: Predominantly extramedullary involvement; similar morphology and immunophenotype to CLL.

  • CLL is the most common leukemia in the Western world and accounts for ~ 30% of all leukemia.
  • SLL accounts for ~7% of Non-Hodgkin lymphoma (NHL)
  • Median 65 years, male predominance, M:F=2:1
  • Most elderly patients with CLL are either asymptomatic (70% of cases) or only mildly symptomatic, whereas some patients may present with fatigue, infection, autoimmune hemolytic anemia, hepatosplenomegaly, lymphadenopathy, or extranodal involvement.
9
Q

Peripheral presentations:

A
  • Lymphocytosis, ≥ 5 × 109/L
  • Typical CLL cells:

-Size: Small and monotonous

oNuclei: Round, condensed chromatin

oNucleoli: Inconspicuous

oCytoplasm: Scant and agranular

§Frequent smudge cells and basket cells

§Prolymphocyte (arrow): variable

oSize: larger

oNuclei: round, more fine chromatin

oNucleoli: prominent

Cytoplasm: abundant

10
Q

Immunophenotype of CLL/SLL

–>Strongly positive _____, _____, ______.

–> Weakly positive_____, ______

Negative in ______, ________.

A
  • Strongly positive: CD5, CD19, CD23
  • Weakly positive: **CD20, **surface immunoglobulin
  • Negative: CD10, FMC7
11
Q

Follicular lymphoma

What is it?

Where is it located mostly?

–80% cases have widespread stage_____ or _____ disease at diagnosis.

A
  • A lymphoma of germinal center B cell origin
  • Frequency: 40% of adult lymphomas in US, 20% worldwide
  • Age: mostly adults, median 60 years
  • Gender: male = female
  • Locations: mostly lymph nodes, also spleen, bone marrow, Waldeyer’s ring, GI tract, skin and soft tissue
  • Clinical presentations: more than 80% cases have widespread stage III or IV disease at diagnosis, 40% have bone marrow involvement; however, patients often asymptomatic except for lymphadenopathy.
12
Q

Things see in Follicular lymphomas:

A
13
Q

Follicular lymphoma

A

What is the function of BCL2?

  • Major function: To suppress apoptosis (programmed cell death).
  • BCL2 gene is down-regulated in the normal germinal center B-cells (so that to allow cells die during selection).
  • Therefore, normal reactive germinal center B-cells are negative for BCL2 protein
14
Q

What is the translocaton?

A

IHG is strong promoter and makes producion of BCL2 increase.

The translocation happens between chromosome 14 and 18.

15
Q

Immunophenotype of Follicular Lymphoma

Positive for markers______ and _______.

Positive for germinal center B- cell marker_______ and _____.

It is positive for ______, which is negative in reactive germinal center B-cells.

Negative for _____ and _____.

A
  • Positive for B-cell markers: CD19, CD20
  • Positive for germinal center B-cell markers: CD10, BCL6
  • Positive for BCL2, which is negative in reactive germinal center B-cells.
  • Negative: CD5*, CD23*
16
Q

Mantle Cell Lymphoma (MCL)

A
  • Comprise approximately 3-10% of NHL
  • Median age 60 years, M:F=2:1
  • Location: mostly lymph nodes, also spleen and bone marrow; most common extranodal sites, gastrointestinal tract and Waldeyer’s ring**
  • Clinical presentations: Most patients present with stage III or IV with lymphadenopathy, hepatosplenomegaly; >50% of cases with massive splenomegaly and marrow involvement
  • In contrast to other small B-cell lymphoma that are mostly indolent, MCL is usually moderately aggressive
17
Q

Mantle cell lymphoma

A
18
Q

Immunophenotype of Mantle Cell Lymphoma

It is positve for ____, which is also positive in CLL/SLL.

Negative for _____, which is positive in CLL/SLL.

Negative for germinal center B cell markers ______ and ______

Positive for _____

A
  • Positive for B-cell markers: CD19, CD20
  • Positive for CD5, which is also positive in CLL/SLL
  • Negative for CD23, which is positive in CLL/SLL
  • Negative for germinal center B-cell markers: CD10, BCL6
  • Positive for cyclin D1 (BCL1), which is negative in most of other B-cell lymphomas.
19
Q

Function of cyclin D1?

A

What is the translocation that happens?

20
Q

Burkitt Lymphoma

A
21
Q

Cytology of Burkitt lymphoma cells?

A

Cytology of Burkitt lymphoma cells

  • Medium sized
  • Round nuclei with one or several small nucleoli
  • Deeply basophilic cytoplasm with lipid vacuoles
22
Q

Burkitt’s lymphoma

A
23
Q

Immunophenotype of Burkitt Lymphoma

A
  • Positive for B-cell markers: CD19, CD20
  • Positive for germinal center B-cell markers: *CD10, *BCL6
  • Negative: CD5, CD23
  • Positive for MYC
24
Q

Translocation in Burkitt’s lymphoma:

A

Prognosis of Burkitts lymphoma: